Harold H. Shlevin

All filings by Harold H. Shlevin on record concern Galectin Therapeutics Inc. In total, 52 filings cover trades dated from 31 May 2018 to 29 June 2026.

Both buying and selling appear: 1 purchase worth €7,230, against 24 sales worth €3.3M. Taken together, the sales exceed the purchases by €3.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 27 option exercises. Since January 2026: no purchases and 2 sales on the market.

The record was last updated on 30 June 2026 with an option exercise in Galectin Therapeutics Inc. The most recent open-market purchase was published on 31 December 2024, 662 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.